{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:38:21Z","timestamp":1786358301632,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04534-0","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:20:03Z","timestamp":1762345203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a single-nephron estimated glomerular filtration rate model to predict disease progression in IgA nephropathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Chen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"10","key":"4534_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347(10):738\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"4534_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12882-025-03958-y","volume":"26","author":"M Rivedal","year":"2025","unstructured":"Rivedal M, Nordb\u00f8 OP, Haaskjold YL, Bj\u00f8rneklett R, Knoop T, Eikrem \u00d8. Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up. BMC Nephrol. 2025;26(1):32.","journal-title":"BMC Nephrol"},{"issue":"12","key":"4534_CR3","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1681\/ASN.2007050526","volume":"18","author":"HN Reich","year":"2007","unstructured":"Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18(12):3177\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4534_CR4","doi-asserted-by":"publisher","first-page":"100693","DOI":"10.1016\/j.xkme.2023.100693","volume":"5","author":"EV Lerma","year":"2023","unstructured":"Lerma EV, Bensink ME, Thakker KM, et al. Impact of proteinuria and kidney function decline on health care costs and resource utilization in adults with IgA nephropathy in the United States: a retrospective analysis. Kidney Med. 2023;5(9):100693.","journal-title":"Kidney Med"},{"issue":"4","key":"4534_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ki.1983.72","volume":"23","author":"BM Brenner","year":"1983","unstructured":"Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983;23(4):647\u201355.","journal-title":"Kidney Int"},{"issue":"February","key":"4534_CR6","first-page":"1228","volume":"39","author":"K Mehmet","year":"2024","unstructured":"Mehmet K, Sidar C, Bc N, Adrian C, Alberto O, Tk R. Glomerular hyperfiltration as a therapeutic target for CKD. Nephrol Dial Transpl. 2024;39(February):1228\u201338.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4534_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/ckj\/sfab267","volume":"15","author":"A Denic","year":"2022","unstructured":"Denic A, Rule AD, Gaillard F. Kidney glomerular filtration rate plasticity after transplantation. Clin Kidney J. 2022;15(5):841\u201344.","journal-title":"Clin Kidney J"},{"issue":"3","key":"4534_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2215\/CJN.03080314","volume":"10","author":"F Cachat","year":"2015","unstructured":"Cachat F, Combescure C, Cauderay M, Girardin E, Chehade H. A systematic review of glomerular hyperfiltration assessment and definition in the medical literature. Clin J Am Soc Nephrol. 2015;10(3):382\u201389.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4534_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12882-023-03137-x","volume":"24","author":"A Kitazawa","year":"2023","unstructured":"Kitazawa A, Fukuda Y. Sex-specific association of body mass index and fatty liver index with prevalence of renal hyperfiltration: a cross sectional study using Japanese health check-up data. BMC Nephrol. 2023;24(1):85.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4534_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12882-022-02735-5","volume":"23","author":"G Akkoc","year":"2022","unstructured":"Akkoc G, Duzova A, Korkmaz A, Oguz B, Yigit S, Yurdakok M. Long-term follow-up of patients after acute kidney injury in the neonatal period: abnormal ambulatory blood pressure findings. BMC Nephrol. 2022;23(1):116.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4534_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12882-022-02709-7","volume":"23","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wu Y. The association between skinfold thicknesses and estimated glomerular filtration rate in adolescents: a cross-sectional study. BMC Nephrol. 2022;23(1):96.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4534_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12882-023-03393-x","volume":"24","author":"HE Babatunde","year":"2023","unstructured":"Babatunde HE, Bello AO, Adeboye MAN, Folayan OS, Ojewole OE, Abubakar U. Cystatin C-derived estimated glomerular filtration rate in children with sickle cell anaemia. BMC Nephrol. 2023;24(1):349.","journal-title":"BMC Nephrol"},{"issue":"6","key":"4534_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/ndt\/gfy332","volume":"35","author":"HA Chakkera","year":"2020","unstructured":"Chakkera HA, Denic A, Kremers WK, et al. Comparison of high glomerular filtration rate thresholds for identifying hyperfiltration. Nephrol Dial Transpl. 2020;35(6):1017\u201326.","journal-title":"Nephrol Dial Transpl"},{"issue":"24","key":"4534_CR14","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","volume":"376","author":"A Denic","year":"2017","unstructured":"Denic A, Mathew J, Lerman LO, et al. Single-nephron glomerular filtration rate in healthy adults. N Engl J Med. 2017;376(24):2349\u201357.","journal-title":"N Engl J Med"},{"issue":"7","key":"4534_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1681\/ASN.0000000000000124","volume":"34","author":"A Denic","year":"2023","unstructured":"Denic A, Mullan AF, Alexander MP, et al. An improved method for estimating nephron number and the association of resulting nephron number estimates with chronic kidney disease outcomes. J Am Soc Nephrol. 2023;34(7):1264\u201378.","journal-title":"J Am Soc Nephrol"},{"key":"4534_CR16","doi-asserted-by":"crossref","unstructured":"Barbour SJ, Coppo R, Zhang H, et al. Evaluating a new international risk-prediction tool in IgA nephropathy. JAMA Intern Med. 2019;179(7).","DOI":"10.1001\/jamainternmed.2019.0600"},{"issue":"3","key":"4534_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.ajkd.2019.02.016","volume":"74","author":"T Chen","year":"2019","unstructured":"Chen T, Li X, Li Y, et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis. 2019;74(3):300\u201309.","journal-title":"Am J Kidney Dis"},{"key":"4534_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.compbiomed.2015.09.003","volume":"66","author":"M Diciolla","year":"2015","unstructured":"Diciolla M, Binetti G, Di Noia T, et al. Patient classification and outcome prediction in IgA nephropathy. Comput Biol Med. 2015;66:278\u201386.","journal-title":"Comput Biol Med"},{"issue":"1","key":"4534_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12882-025-04049-8","volume":"26","author":"J Gonz\u00e1lez Rodr\u00edguez","year":"2025","unstructured":"Gonz\u00e1lez Rodr\u00edguez J, Valdivielso JM, Jatem Escalante E, et al. Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA nephropathy. BMC Nephrol. 2025;26(1):141.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4534_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12882-025-04253-6","volume":"26","author":"Z Hu","year":"2025","unstructured":"Hu Z, Bu S, Wang K, et al. Classification of primary glomerulonephritis using machine learning models: a focus on IgA nephropathy prediction. BMC Nephrol. 2025;26(1):289.","journal-title":"BMC Nephrol"},{"issue":"10","key":"4534_CR21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1681\/ASN.2010010117","volume":"21","author":"C Pozzi","year":"2010","unstructured":"Pozzi C, Andrulli S, Pani A, et al. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol. 2010;21(10):1783\u201390.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4534_CR22","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","volume":"65","author":"BD Maes","year":"2004","unstructured":"Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int. 2004;65(5):1842\u201349.","journal-title":"Kidney Int"},{"issue":"23","key":"4534_CR23","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen T, Eitner F, Fitzner C, et al. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med. 2015;373(23):2225\u201336.","journal-title":"N Engl J Med"},{"issue":"5","key":"4534_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv J, Zhang H, Wong MG, et al. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the testing randomized clinical trial. JAMA. 2017;318(5):432\u201342.","journal-title":"JAMA"},{"issue":"19","key":"4534_CR25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"5","key":"4534_CR26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534\u201345.","journal-title":"Kidney Int"},{"issue":"5","key":"4534_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"ISD Roberts","year":"2009","unstructured":"Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546\u201356.","journal-title":"Kidney Int"},{"issue":"5","key":"4534_CR28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014\u201321.","journal-title":"Kidney Int"},{"issue":"1","key":"4534_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50529-x","volume":"9","author":"T Sasaki","year":"2019","unstructured":"Sasaki T, Tsuboi N, Okabayashi Y, et al. Estimation of nephron number in living humans by combining unenhanced computed tomography with biopsy-based stereology. Sci Rep. 2019;9(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"17","key":"4534_CR30","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.","journal-title":"N Engl J Med"},{"issue":"7","key":"4534_CR31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00125-021-05444-0","volume":"64","author":"L Chan","year":"2021","unstructured":"Chan L, Nadkarni GN, Fleming F, et al. Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia. 2021;64(7):1504\u201315.","journal-title":"Diabetologia"},{"issue":"7","key":"4534_CR32","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41591-023-02418-0","volume":"29","author":"LA Inker","year":"2023","unstructured":"Inker LA, Collier W, Greene T, et al. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure. Nat Med. 2023;29(7):1867\u201376.","journal-title":"Nat Med"},{"key":"4534_CR33","first-page":"387","volume":"7","author":"J Ye","year":"2024","unstructured":"Ye J, Gao X, Huang X, et al. Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma. Res (Wash, DC). 2024;7:387.","journal-title":"Res (Wash, DC)"},{"issue":"4","key":"4534_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41440-018-0116-3","volume":"42","author":"E Mishima","year":"2019","unstructured":"Mishima E, Haruna Y, Arima H. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials. Hypertens Res. 2019;42(4):469\u201382.","journal-title":"Hypertens Res"},{"issue":"5","key":"4534_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","volume":"67","author":"X Xie","year":"2016","unstructured":"Xie X, Liu Y, Perkovic V, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728\u201341.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4534_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ki.2011.79","volume":"80","author":"FA Holtkamp","year":"2011","unstructured":"Holtkamp FA, de Zeeuw D, Thomas MC, et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int. 2011;80(3):282\u201387.","journal-title":"Kidney Int"},{"issue":"3","key":"4534_CR37","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.kint.2016.09.038","volume":"91","author":"CM Clase","year":"2017","unstructured":"Clase CM, Barzilay J, Gao P, et al. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Kidney Int. 2017;91(3):683\u201390.","journal-title":"Kidney Int"},{"issue":"5","key":"4534_CR38","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.kint.2020.12.034","volume":"99","author":"N Saga","year":"2021","unstructured":"Saga N, Sakamoto K, Matsusaka T, Nagata M. Glomerular filtrate affects the dynamics of podocyte detachment in a model of diffuse toxic podocytopathy. Kidney Int. 2021;99(5):1149\u201361.","journal-title":"Kidney Int"},{"issue":"4","key":"4534_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.kint.2016.01.001","volume":"89","author":"M Tavasoli","year":"2016","unstructured":"Tavasoli M, Li L, Al-Momany A, et al. The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury. Kidney Int. 2016;89(4):833\u201347.","journal-title":"Kidney Int"},{"issue":"6","key":"4534_CR40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/sj.ki.5000210","volume":"69","author":"S Sachetelli","year":"2006","unstructured":"Sachetelli S, Liu Q, Zhang SL, et al. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int. 2006;69(6):1016\u201323.","journal-title":"Kidney Int"},{"issue":"6","key":"4534_CR41","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.ekir.2021.02.018","volume":"6","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Mani K, Swamy A, et al. Supportive management of IgA nephropathy with renin-angiotensin blockade, the AIIMS primary IgA nephropathy cohort (APPROACH) study. Kidney Int Rep. 2021;6(6):1661\u201368.","journal-title":"Kidney Int Rep"},{"issue":"7","key":"4534_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-022-00559-y","volume":"18","author":"M Cortinovis","year":"2022","unstructured":"Cortinovis M, Perico N, Ruggenenti P, Remuzzi A, Remuzzi G. Glomerular hyperfiltration. Nat Rev Nephrol. 2022;18(7):435\u201351.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"4534_CR43","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJMoa2409415","volume":"392","author":"HJL Heerspink","year":"2025","unstructured":"Heerspink HJL, Jardine M, Kohan DE, et al. Atrasentan in patients with IgA nephropathy. N Engl J Med. 2025;392(6):544\u201354.","journal-title":"N Engl J Med"},{"issue":"6","key":"4534_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon V, Thomson SC. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020;16(6):317\u201336.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4534_CR45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502\u201317.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04534-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:27:25Z","timestamp":1786357645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04534-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4534"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04534-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article updated for correction in author affiliation","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was performed in compliance with the Declaration of Helsinki. It has obtained approval from the Institutional Review Board of Chinese PLA General Hospital, with the approval number S2023-467\u201301. The ethics committee also granted a waiver of the informed consent form. As a retrospective observational study, it utilized pre-existing data without any study-related interventions. To safeguard the privacy of participants, all data used were de-identified prior to receipt and analysis.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"620"}}